The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
- PMID: 16452181
- DOI: 10.1158/0008-5472.CAN-05-3427
The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
Abstract
The activity of mammalian SWI/SNF-related chromatin remodeling complexes is crucial for differentiation, development, and tumor suppression. Cell cycle-regulating activities dependent on the complexes include induction of the p21(WAF1/CIP1) kinase inhibitor and repression of E2F-responsive promoters. These responses are linked through effects on pRb phosphorylation, but the direct role of the SWI/SNF-related complexes in their regulation is not fully understood. Results presented here reveal that the complexes are required for regulation of a distinct pathway of proliferation control involving repression of c-myc expression in differentiating cells. This involves direct promoter targeting of the c-myc gene by the complexes. Induction of p21(WAF1/CIP1) is specifically dependent on prior repression of c-myc, but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21(WAF1/CIP1).
Similar articles
-
The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.Cancer Res. 2005 Oct 15;65(20):9236-44. doi: 10.1158/0008-5472.CAN-05-1225. Cancer Res. 2005. PMID: 16230384
-
De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.Int J Oncol. 2008 Aug;33(2):375-80. Int J Oncol. 2008. PMID: 18636159
-
DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.Cancer Res. 2006 Jul 1;66(13):6579-88. doi: 10.1158/0008-5472.CAN-05-2415. Cancer Res. 2006. PMID: 16818630
-
When the SWI/SNF complex remodels...the cell cycle.Oncogene. 2001 May 28;20(24):3067-75. doi: 10.1038/sj.onc.1204331. Oncogene. 2001. PMID: 11420722 Review.
-
Lost in transcription: p21 repression, mechanisms, and consequences.Cancer Res. 2005 May 15;65(10):3980-5. doi: 10.1158/0008-5472.CAN-04-3995. Cancer Res. 2005. PMID: 15899785 Review.
Cited by
-
ARID1A mutations in cancer: another epigenetic tumor suppressor?Cancer Discov. 2013 Jan;3(1):35-43. doi: 10.1158/2159-8290.CD-12-0361. Epub 2012 Dec 3. Cancer Discov. 2013. PMID: 23208470 Free PMC article. Review.
-
Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes.Int J Hepatol. 2014;2014:791045. doi: 10.1155/2014/791045. Epub 2014 Dec 17. Int J Hepatol. 2014. PMID: 25580300 Free PMC article.
-
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.Mol Cancer Ther. 2018 Dec;17(12):2767-2779. doi: 10.1158/1535-7163.MCT-18-0348. Epub 2018 Sep 19. Mol Cancer Ther. 2018. PMID: 30232145 Free PMC article.
-
Multiple distinct stimuli increase measured nucleosome occupancy around human promoters.PLoS One. 2011;6(8):e23490. doi: 10.1371/journal.pone.0023490. Epub 2011 Aug 11. PLoS One. 2011. PMID: 21853138 Free PMC article.
-
A rationale to target the SWI/SNF complex for cancer therapy.Trends Genet. 2014 Aug;30(8):356-63. doi: 10.1016/j.tig.2014.05.001. Epub 2014 Jun 3. Trends Genet. 2014. PMID: 24932742 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources